Improving Access to Life Science Patient Support Programs at the Provider Level

The COVID-19 pandemic has exacerbated an already significant problem in the United States: financial toxicity among cancer patients—and their providers. Now more than ever, it is imperative that patients be connected with available financial assistance.

Tim Koenig, VP of Marketing and Life Science Solutions at Annexus Health, takes a closer look at this problem and explains how life science organizations can take a more active role in combating financial toxicity by helping to streamline access to patient support programs.